ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial.

Patients with structural CMD had a greater numerical increment in exercise time in response to amlodipine than ranolazine (mean difference in delta, 46 s [95% CI, –2 to 93 s], P =0.056), but this did not reach statistical significance.

also in 111,027 other papers